The new antibody test has been developed from scratch in close collaboration between Rigshospitalet, the University of Copenhagen and Novo Nordisk A/S, with support from the Carlsberg Foundation and the Novo Nordisk Foundation. The test can make a major contribution to monitoring the transmission of COVID-19 during the pandemic and the antibody response at the individual level and in society as a whole.
Read more about the antibody test on Sciencenews.dk.
Antibody trial will determine whether the immune system remembers the new coronavirus
A new research project will investigate the transmission of COVID-19 among people in the labour market in Denmark.
The new project is a collaboration between researchers at Rigshospitalet, Herlev & Gentofte Hospital and the University of Copenhagen, Aarhus University, Statens Serum Institut and Novo Nordisk A/S.
The trial participants will be employees in Denmark of Novo Nordisk A/S, Novozymes A/S (Novonesis), Novo Holdings A/S and the Novo Nordisk Foundation, including their partners and their adult children. The researchers hope that up to 40,000 people will participate in the project and be tested for antibodies against the disease.
The Novo Nordisk Foundation has awarded DKK 20 million to the project.
Read more about the antibody trial here and on Sciencenews.dk.
